Zacks.com on MSN29m
AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to KnowAbbVie (ABBV) reachead $188.57 at the closing of the latest trading day, reflecting a -0.99% change compared to its last close.
Hosted on MSN5m
Continuous Parkinson's Disease Therapy Wins FDA Nod"For too long, the Parkinson's community has had limited treatment options for advanced disease," Robert Hauser, MD, MBA, of ...
The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...
The company collaborates with AbbVie in marketing several of its developed inhibitors, with more promising treatments in the ...
The board of directors of (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on December 10, 2024, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback